-
The company repeatedly mentions to replicate the BOTTOM OF PYRAMID (BOP) STRATEGY which they have been using in LatM markets , in USA market. Not able to get clarity on it. What is it and How will it work?
-
What is a good expectation to build in for EBITDA MARGINS of Injectables to be sold in US?
| Subscribe To Our Free Newsletter |
